Overview
Jeanmarie Fitzpatrick is a Hematologist and an Oncologist in Berwyn, Pennsylvania. Ms. Fitzpatrick is rated as an Experienced provider by MediFind in the treatment of Pancreatic Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer. Ms. Fitzpatrick is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1001 Chesterbrook Boulevard, Berwyn, PA 19312
Jefferson Surgery - Honickman Center
Charles Yeo is an Oncologist and a General Surgeon in Philadelphia, Pennsylvania. Dr. Yeo is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Yeo is currently accepting new patients.
LG Health Physicians Hematology And Medical Oncology
Efrat Dotan is a Hematologist and an Oncologist in Lancaster, Pennsylvania. Dr. Dotan is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Dotan is currently accepting new patients.
David Tuveson is an Oncologist in Philadelphia, Pennsylvania. Dr. Tuveson is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Trophoblastic Tumor Placental Site, Hepato-Pancreato-Biliary Surgery, and Pancreatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerMs. Fitzpatrick isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.

